Cite
MLA Citation
E. Hill et al.. “130: Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): initial outcomes from 2 years' experience at the Oxford Cancer Centre, Oxford University Hospitals NHS Trust.” Lung cancer, vol. 87, n.d., pp. S47–. http://access.bl.uk/ark:/81055/vdc_100048592401.0x000001